Patent · US Active

Integrated blood treatment module

US8206580B2 · kind B2 · utility

11Cited by
38References
49Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2004
Grant dateJun 26, 2012
Priority date
Expiry dateOct 25, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2205/12
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

An integrated blood treatment module comprises a blood treatment device (1) having a housing (2) and a first end-cap (4) and a second end-cap (5) closing both ends of the housing (2). A pump hose (17) for a peristaltic pump has a first end (18) that is secured to the housing (2) and a second end (16) that is connected to a blood inlet port (15) of the first end-cap (4) so as to form a loop. A degassing device (30) is connected to the second end-cap (5). The degassing device (30), which, in use, is full of liquid, comprises a hydrophobic membrane through which bubbles and micro-bubbles escape the degassing device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.